Today’s 5G, and tomorrow’s 6G, could ensure that the invisible systems powering modern life never go dark, while also ...

Kyle Pedretty Ph.D., Nicole Sassu Ph.D. In a June 23, 2026, precedential ruling, the U.S. Court of Appeals for the Federal Circuit affirmed a decision by the U.S. District Court for the District of ...

Read full article: Beautiful Sunday before warmer weather arrives in Southeast Michigan Police reported that one person is in custody after a shooting inside the Great Lakes Crossing Outlets on ...

Priority Waste hired a new CEO who is expected to address service issues. The company took over a large number of contracts locally after it acquired GFL. The service disruptions have lingered since ...

Nearly four months after parting ways with its founder and CEO, Metro Detroit's most prominent waste hauler has a new boss and a new parent company. Priority Waste announced Monday the appointment of ...

Bayer announced today that the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) and granted Priority Review designation for KERENDIA ® (finerenone), which ...

NEW YORK – Bayer said on Monday that the US Food and Drug Administration granted priority review to its application seeking approval for Hyrnuo (sevabertinib) as a first-line treatment for ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that the U.S. Food and Drug Administration (FDA) has granted HYRNUO ® (sevabertinib) Priority Review status for the first-line treatment of adult ...

May 4 (Asia Today) --Seoul accounted for more than 80% of first-priority apartment subscription applications in South Korea in March, according to an analysis by real estate platform Zigbang. Zigbang ...

– Novel Investigational Combination Pairs Bictegravir, Guideline-Recommended INSTI with High Barrier to Resistance, with Lenacapavir, a First-in-Class Capsid Inhibitor, Designed for Sustained ...

U.S. FDA Grants Priority Review of New Drug Application for Gilead’s Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir – Novel Investigational Combination Pairs Bictegravir, ...